FDA accepts resubmitted BLA for Atara's tabelecleucel with 2027 target date

Go back to FDA accepts resubmitted BLA for Atara's tabelecleucel with 2027 target date
(NASDAQ: ATRA) Delayed: 9.35 +0.19 (2.07%)
Previous Close $9.16    52 Week High $40.80 
Open $9.25    52 Week Low $12.45 
Day High $9.43    P/E N/A 
Day Low $9.17    EPS $0.00 
Volume 26,545